AAREYDRUGS vs MEDICO: Stock Comparison

Aarey Drugs & Pharmaceuticals Limited vs Medico Remedies Limited

Live data: 29 April 2026, 4:01 PM IST • Source: NSE and company filings

Medico Remedies Limited is the larger company by market capitalisation. Medico Remedies Limited shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Aarey Drugs & Pharmaceuticals Limited and Medico Remedies Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AAREYDRUGS is more favourable on 1 of 13 scored metrics and MEDICO on 11These counts are context-free and are not an overall rating.

Key Differences

Market Cap
MEDICO is the larger company
₹317 Cr vs ₹221 Cr
P/E Ratio
MEDICO has a lower P/E
27.22x vs 55.36x
P/B Ratio
AAREYDRUGS has a lower P/B
1.46x vs 4.73x
EPS
MEDICO has higher earnings per share
₹1.58 vs ₹1.47
Revenue Growth (TTM YoY)
MEDICO has faster revenue growth
37.5% vs 19.8%
EPS Growth (TTM YoY)
MEDICO has faster EPS growth
36.5% vs -41.05%
Qtr Sales Growth
MEDICO has stronger quarterly sales growth
37.6% vs 0%
Qtr Profit Growth
MEDICO has stronger quarterly profit growth
35% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAAREYDRUGSMEDICO
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricAAREYDRUGSMEDICO
Live Price₹90.51₹38.87
Day Change-4.92%0.65%
Volume2.2 L19,197
52-Week High₹96₹56.88
52-Week Low₹50.31₹30.22
Distance from 52W High-5.72%-31.66%

Valuation

MetricAAREYDRUGSMEDICO
Market Cap₹221 Cr₹317 Cr
P/E Ratio55.36x27.22x
P/B Ratio1.46x4.73x
EPS₹1.47₹1.58
Book Value₹48.67₹9.15
Dividend Yield0%0%

Growth

MetricAAREYDRUGSMEDICO
Revenue Growth (TTM YoY)19.8%37.5%
EPS Growth (TTM YoY)-41.05%36.5%
Qtr Sales Growth0%37.6%
Qtr Profit Growth0%35%

Profitability & Leverage

MetricAAREYDRUGSMEDICO
ROE2.64%19%
ROCE6%23.1%
Net Margin0.84%6.36%
Operating Margin2.21%8.25%
Debt to Equity0.33x0.25x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricAAREYDRUGSMEDICO
Promoter Holding37.71% 1.35 pp61.38%
FII Holding4.18% 0.32 pp0.03% 0.46 pp
DII Holding1.62% 1.62 pp0%
Public Holding56.49% 0.6 pp38.59% 0.46 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Aarey Drugs & Pharmaceuticals Limited and Medico Remedies Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.